BMS-986521
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-986521, covering 2026-01-07 to 2026-01-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants. [Phase 1]